secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001641489-26-000005
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

vTv Therapeutics posts updated investor slide presentation on February 26, 2026
-------------------------------------------------------------------------------

- Company posted updated investor presentation dated February 2026 on its website.
- Presentation will be used in meetings with investors, analysts, and other parties.
- Presentation attached as Exhibit 99.1 to Current Report on Form 8-K filed February 26, 2026.
- CEO Paul J. Sekhri signed the 8-K filing for vTv Therapeutics Inc. (Nasdaq: VTVT).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/0001641489-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/vtvt-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001641489-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer